Abstract:This study describes the synthesis, surface analysis, and biological evaluation of bioactive titanium surfaces. The aim was to achieve an improved effect on osteoinduction in dental and orthopedic implants. For this purpose, a chemistry was developed, which allows to bind the bioactive cyclopeptide cRGDfK covalently to biomedically used titanium via polyethylene glycol linkers of different lengths. The chemical process is practicable, robust, and metal-free. The resulting chemically modified titanium plates sh… Show more
“…When the complexes EXO-PEPs were constructed and incubated on the titanium surface, EXO-PEP1 adsorbed in the least quantity and the most connected was EXO-PEP3, suggesting PEP1 gained the low ability targeting to the titanium and PEP3 affinity as TBP3, which indicating PEP3 retained the fully titanium targeting of TBP motif and the exosomal anchoring of CP05 motif simultaneously [ 56 ]. The result of IVIS showed the similar result in vivo.…”
Background
Exosomes derived from bone marrow mesenchymal stem cells (BMSC-exos) have been shown triggering osteogenic differentiation and mineralization of MSCs, but exosomes administered via bolus injections are rapidly sequestered and cleared. Therefore, we considered the implant as a new organ of patient’s body and expected to find a method to treat implant with BMSC-exos in vivo directly.
Methods
A fusion peptide (PEP), as a drug delivery system (DDS) which contained a titanium-binding peptide (TBP) possessing the ability to selectively bind to the titanium surface and another peptide CP05 being able to capture exosomes expertly, is constructed to modify the titanium surface.
Results
Both in vitro and in vivo experiments prove PEP retains the ability to bind titanium and exosome simultaneously, and the DDS gain the ability to target exosomes to titanium implants surface following enhancing osseointegration post-implantation. Moreover, the DDS constructed by exosomes of diverse origins shows the similar combination rate and efficiency of therapy.
Conclusion
This drug delivery system demonstrates the concept that EXO-PEP system can offer an accurate and efficient therapy for treating implants with long-term effect.
“…When the complexes EXO-PEPs were constructed and incubated on the titanium surface, EXO-PEP1 adsorbed in the least quantity and the most connected was EXO-PEP3, suggesting PEP1 gained the low ability targeting to the titanium and PEP3 affinity as TBP3, which indicating PEP3 retained the fully titanium targeting of TBP motif and the exosomal anchoring of CP05 motif simultaneously [ 56 ]. The result of IVIS showed the similar result in vivo.…”
Background
Exosomes derived from bone marrow mesenchymal stem cells (BMSC-exos) have been shown triggering osteogenic differentiation and mineralization of MSCs, but exosomes administered via bolus injections are rapidly sequestered and cleared. Therefore, we considered the implant as a new organ of patient’s body and expected to find a method to treat implant with BMSC-exos in vivo directly.
Methods
A fusion peptide (PEP), as a drug delivery system (DDS) which contained a titanium-binding peptide (TBP) possessing the ability to selectively bind to the titanium surface and another peptide CP05 being able to capture exosomes expertly, is constructed to modify the titanium surface.
Results
Both in vitro and in vivo experiments prove PEP retains the ability to bind titanium and exosome simultaneously, and the DDS gain the ability to target exosomes to titanium implants surface following enhancing osseointegration post-implantation. Moreover, the DDS constructed by exosomes of diverse origins shows the similar combination rate and efficiency of therapy.
Conclusion
This drug delivery system demonstrates the concept that EXO-PEP system can offer an accurate and efficient therapy for treating implants with long-term effect.
“…Biomaterial implants are commonly used to replace and restore damaged or deteriorated organs or tissues in the human body [2]. This includes dental and orthopedic implants, ligaments, intraocular lenses, vascular grafts, artificial hearts, heart valves, biosensors, and cardiac pacemakers [5][6][7][8][9][10][11][12][13]. An implant should function flawlessly for a lifetime.…”
Metal injection molding (MIM) is one of the most widely used manufacturing processes worldwide as it is a cost-effective way of producing a variety of dental and orthopedic implants, surgical instruments, and other important biomedical products. Titanium (Ti) and Ti alloys are popular modern metallic materials that have revamped the biomedical sector as they have superior biocompatibility, excellent corrosion resistance, and high static and fatigue strength. This paper systematically reviews the MIM process parameters that extant studies have used to produce Ti and Ti alloy components between 2013 and 2022 for the medical industry. Moreover, the effect of sintering temperature on the mechanical properties of the MIM-processed sintered components has been reviewed and discussed. It is concluded that by appropriately selecting and implementing the processing parameters at different stages of the MIM process, defect-free Ti and Ti alloy-based biomedical components can be produced. Therefore, this present study could greatly benefit future studies that examine using MIM to develop products for biomedical applications.
“…The past decade has witnessed the evolution of polymeric surface coatings from a simple protection barrier to a functional interface, which imparts functional attributes to the material through specific interactions and communication with its environment. In particular, polymeric coatings bearing bioactive ligands ranging from small molecules to biomacromolecules play a critical role in realizing various diagnostic and biosensing platforms. − For such applications, a polymeric coating that is stable in an aqueous environment, inherently anti-biofouling, and can be easily conjugated with biological probes is often desirable. In light of the demand for workability under aqueous conditions, as a general approach, hydrophilic polymers are chemically tethered onto the underlying inorganic substrate through either a “graft-to” or “graft-from” approach.…”
Facile and effective functionalization of the interface
of polymer-coated
surfaces allows one to dictate the interaction of the underlying material
with the chemical and biological analytes in its environment. Herein,
we outline a modular approach that would enable installing a variety
of “clickable” handles onto the surface of polymer brushes,
enabling facile conjugation of various ligands to obtain functional
interfaces. To this end, hydrophilic anti-biofouling poly(ethylene
glycol)-based polymer brushes are fabricated on glass-like silicon
oxide surfaces using reversible addition–fragmentation chain
transfer (RAFT) polymerization. The dithioester group at the chain-end
of the polymer brushes enabled the installation of azide, maleimide,
and terminal alkene functional groups, using a post-polymerization
radical exchange reaction with appropriately functionalized azo-containing
molecules. Thus, modified polymer brushes underwent facile conjugation
of alkyne or thiol-containing dyes and ligands using alkyne–azide
cycloaddition, Michael addition, and radical thiol–ene conjugation,
respectively. Moreover, we demonstrate that the radical exchange approach
also enables the installation of multivalent motifs using dendritic
azo-containing molecules. Terminal alkene groups containing dendrons
amenable to functionalization with thiol-containing molecules using
the radical thiol–ene reaction were installed at the interface
and subsequently functionalized with mannose ligands to enable sensing
of the Concanavalin A lectin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.